Zenas BioPharma, Inc. Current Income Tax Expense (Benefit)
Zenas BioPharma, Inc. (ZBIO) reported Current Income Tax Expense (Benefit) of -$79.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-03-16
- Zenas BioPharma, Inc. current income tax expense (benefit) for fiscal 2025 was -$79.00K, a 118.41% decline from fiscal 2024.
- Zenas BioPharma, Inc. current income tax expense (benefit) for fiscal 2024 was $429.00K, a 42.52% increase from fiscal 2023.
- Zenas BioPharma, Inc. current income tax expense (benefit) for fiscal 2023 was $301.00K.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$79.00K 10-K · filed 2026-03-16 |
| 2024-12-31 | $429.00K 10-K · filed 2026-03-16 |
| 2023-12-31 | $301.00K 10-K · filed 2025-03-11 |